Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Nov 8, 2024

Accession no.
0001415889-24-026444
Filed
Nov 8, 2024
Trade date
Nov 6-7, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 25 non-derivative transactions and 5 derivative transactions. Open-market sales total $9.97M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 6, 2024Common StockMOption exerciseAcquired+4,500$120.26+$541,1704,500Indirect
Nov 6, 2024Common StockMOption exerciseAcquired+3,000$102.11+$306,3307,500Indirect
Nov 6, 2024Common StockSSaleDisposed−800$391.70−$313,3606,700Indirect
Nov 6, 2024Common StockSSaleDisposed−1,592$392.77−$625,289.845,108Indirect
Nov 6, 2024Common StockSSaleDisposed−1,507$393.94−$593,667.583,601Indirect
Nov 6, 2024Common StockSSaleDisposed−204$395.28−$80,637.123,397Indirect
Nov 6, 2024Common StockSSaleDisposed−1,100$396.16−$435,7762,297Indirect
Nov 6, 2024Common StockSSaleDisposed−972$397.16−$386,039.521,325Indirect
Nov 6, 2024Common StockSSaleDisposed−1,025$397.99−$407,939.75300Indirect
Nov 6, 2024Common StockSSaleDisposed−300$398.90−$119,6700Indirect
Nov 6, 2024Common StockMOption exerciseAcquired+2,500$111.00+$277,5002,500Indirect
Nov 6, 2024Common StockSSaleDisposed−777$392.36−$304,863.721,723Indirect
Nov 6, 2024Common StockSSaleDisposed−300$393.42−$118,0261,423Indirect
Nov 6, 2024Common StockSSaleDisposed−300$394.25−$118,2751,123Indirect
Nov 6, 2024Common StockSSaleDisposed−530$396.55−$210,171.5593Indirect
Nov 6, 2024Common StockSSaleDisposed−493$397.60−$196,016.8100Indirect
Nov 6, 2024Common StockSSaleDisposed−100$398.62−$39,8620Indirect
Nov 7, 2024Common StockMOption exerciseAcquired+11,250$102.11+$1,148,737.511,250Indirect
Nov 7, 2024Common StockSSaleDisposed−2,304$400.39−$922,498.568,946Indirect
Nov 7, 2024Common StockSSaleDisposed−5,702$401.55−$2,289,638.13,244Indirect
Nov 7, 2024Common StockSSaleDisposed−2,640$402.40−$1,062,336604Indirect
Nov 7, 2024Common StockSSaleDisposed−604$403.14−$243,496.560Indirect
Nov 7, 2024Common StockMOption exerciseAcquired+3,750$111.00+$416,2503,750Indirect
Nov 7, 2024Common StockSSaleDisposed−1,895$400.30−$758,568.51,855Indirect
Nov 7, 2024Common StockSSaleDisposed−1,855$401.65−$745,060.750Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 6, 2024Common StockMOption exerciseDisposed−4,500$0.00$00Indirect
Nov 6, 2024Common StockMOption exerciseDisposed−3,000$0.00$049,500Indirect
Nov 6, 2024Common StockMOption exerciseDisposed−2,500$0.00$049,500Indirect
Nov 7, 2024Common StockMOption exerciseDisposed−11,250$0.00$038,250Indirect
Nov 7, 2024Common StockMOption exerciseDisposed−3,750$0.00$045,750Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)